Medicaid work requirements 2027 land on payers, not states
The community engagement rules take effect January 1, 2027, but the operational burden of exemption checks, procedural terminations and mid-year churn falls on the managed care plans holding the risk.
Medicaid work requirements 2027 is being covered almost entirely as a state government story: which agencies have verification systems, which have asked for delay, which will process exemptions by hand. That framing misses where the financial and clinical consequences actually settle. States determine eligibility, but managed care organizations hold the risk contracts, and they are the ones that will carry a mid-contract-year membership shock into their 2027 books.
What takes effect on January 1, 2027
The 2025 reconciliation law established federal community engagement requirements for certain Medicaid enrollees, with a statutory effective date of January 1, 2027. The Center for Health Care Strategies published a summary of the federal baseline in June 2026 covering which populations are in scope, which exemption categories apply and how often enrollees must report. KFF maintains a live tracker of state-by-state implementation, including which states have approved verification systems in place. Plans should be pulling both at press time rather than relying on summaries from earlier in the cycle, because state postures are still moving.
The compliance clock is now inside six months. That matters less for policy teams, who have been reading draft guidance for a year, than for operations. Eligibility file exchanges, member outreach campaigns, care management triage lists and actuarial assumptions all have build times measured in quarters, not weeks. Anything not scoped by late summer is unlikely to be production-ready for a January start.
States determine eligibility. Plans absorb the consequences. Those are not the same problem, and only one of them has a budget line.
Exemption determination is a data-matching problem first
Avalere Health's July 2026 guidance identifies exemption determination as the operational choke point, and that framing is the most useful one available to payers. Most enrollees who are at risk of losing coverage are not people who fail to meet the requirement. They are people who meet it, or qualify for an exemption, and cannot prove it through the channel the state has built. Medical frailty, caregiving status, student enrollment, substance use disorder treatment and short-term illness all have to be evidenced against data the state may not hold.
Plans often do hold that data, or adjacent signals for it. Claims history, pharmacy fills, care management notes, prior authorization records and disability-related service utilization are all potential exemption evidence. The question is whether a plan has a legal pathway and a technical pipeline to surface that evidence to the state agency before a termination notice goes out, rather than reconstructing it during an appeal. That is a data-sharing agreement and an interface, and both take longer to negotiate than to build.
The unwinding precedent says the failures will be procedural
The 2023-24 Medicaid unwinding is the closest available analogue, and its central lesson was that the large majority of disenrollments were procedural rather than eligibility-based, according to KFF's tracking at the time. People lost coverage because paperwork did not reach them, was not returned, or was returned incorrectly. Leaders should confirm the currently published percentage before citing it, but the directional finding has been consistent across state reporting.
The 2027 environment is harder in one important respect. During the unwinding, many disenrolled adults could move to marketplace coverage with enhanced subsidies. That off-ramp has narrowed. Spotlight PA reported in May 2026 that ACA enrollment fell 21% as premiums rose following the expiration of enhanced subsidies. An adult who loses Medicaid for a missed reporting deadline in 2027 is more likely to become uninsured than to land in a plan's exchange book.
What churn does to a plan's 2027 economics
Every procedural disenrollment is a member lost mid-contract-year. The immediate effect is revenue, but the more durable effect is selection. Members who navigate a reporting requirement successfully skew toward those with stable housing, reliable mail, digital access and fewer competing demands. The members who fall off skew the other way, and many of them return within months once they reengage with the system, often sicker and with a gap in medication adherence behind them.
The quality consequences arrive on a delay. HEDIS and star ratings denominators move when membership moves, and they move for reasons that have nothing to do with the care a plan delivered. A plan can lose measure performance on continuous enrollment criteria alone. Meanwhile provider networks absorb the uncompensated care from members who present without coverage, which surfaces later as contracting pressure.
This lands on a membership base that is already thinning. Healthcare Dive reported in February 2026 that Medicare Advantage growth is decelerating as insurers shed members for 2026, and Healthcare Brew reported in August 2026 that insurers are performing well but face looming challenges. Medicaid churn is not arriving into a growth environment. It is arriving on top of contraction.
The three executive workstreams to stand up now
For CFOs, the work is actuarial. Churn assumptions need to be in 2027 bids and reserve models now, with sensitivity ranges rather than a point estimate, because state implementation variation will be wide. A plan operating in six states should not assume a single disenrollment rate across them.
For CIOs, the work is plumbing. Eligibility data-sharing pipelines with state agencies have to exist before January, not after the first termination file arrives. That includes the return path: knowing within days, not at the next monthly reconciliation, which members have been terminated and why.
For chief medical officers, the work is triage. Plans should be able to identify today which high-utilizing members are likely to be in scope and at risk, including members mid-treatment for cancer, transplant follow-up, dialysis, pregnancy-adjacent care and behavioral health. Those lists are the basis for targeted outreach, and they are also the basis for the clinical argument a plan will need to make when it asks a state for an exemption reconsideration.
